Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $240K | $1.1M | $5.6M | $8.7M | |
Selling, General & Admin | $528.1K | $4.9M | $11.4M | $6.6M | $8.3M | |
Other Inc / (Exp) | $25.7K | -$5.1M | $377K | $165.2K | $366.1K | |
Operating Expenses | $550.6K | $8.1M | $21.9M | $17.7M | $22.6M | |
Operating Income | -$550.6K | -$8.1M | -$21.9M | -$17.7M | -$22.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$512.7K | -$13.2M | -$21.5M | -$17.4M | -$21.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$13.2M | -$21.5M | -$17.4M | -$21.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$512.7K | -$13.2M | -$21.5M | -$17.4M | -$21.8M | |
Basic EPS (Cont. Ops) | -$0.16 | -$1.92 | -$1.60 | -$1.10 | -$1.00 | |
Diluted EPS (Cont. Ops) | -$0.16 | -$1.92 | -$1.60 | -$1.10 | -$1.00 | |
Weighted Average Basic Share | $3.1M | $6.9M | $13.5M | $16.8M | $21.8M | |
Weighted Average Diluted Share | $3.1M | $6.9M | $13.5M | $16.8M | $21.8M | |
EBITDA | -$486.9K | -$13.2M | -$21.3M | -$16.9M | -$21.1M | |
EBIT | -$509.4K | -$13.2M | -$21.5M | -$17.4M | -$21.7M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$550.6K | -$8.1M | -$21.9M | -$17.7M | -$22.6M | |
Operating Income (Adjusted) | -$509.4K | -$13.2M | -$21.5M | -$17.4M | -$21.7M |
Period Ending | 2021-01-04 | 2022-01-04 | 2023-01-04 | 2024-01-04 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-01-04 | 2022-01-04 | 2023-01-04 | 2024-01-04 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2021-01-04 | 2022-01-04 | 2023-01-04 | 2024-01-04 | 2025-01-04 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1M | $1.7M | $5.7M | $11.9M | $33.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $29.2K | $340 | $22.5K | $228.4K | $2.3M | |
Inventory | -- | -- | -- | -- | $16.9K | |
Prepaid Expenses | $17.1K | $49.1K | $144.2K | $588.4K | $6.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.2M | $1.7M | $5.8M | $12.8M | $41.5M | |
Property Plant And Equipment | $862.8K | $1M | $3.8M | $7M | $13.9M | |
Long-Term Investments | -- | -- | $250K | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2M | $2.8M | $9.9M | $22.8M | $55.4M | |
Accounts Payable | $3.8K | $286.9K | $1.7M | $711K | $1.3M | |
Accrued Expenses | -- | $258K | $221.6K | $455.2K | $259.3K | |
Current Portion Of Long-Term Debt | -- | -- | $5.6K | $6K | $6.4K | |
Current Portion Of Capital Lease Obligations | $17.8K | $81.1K | $128.7K | $376.7K | $439.4K | |
Other Current Liabilities | $18.1K | -- | -- | -- | -- | |
Total Current Liabilities | $65K | $637K | $2.1M | $1.6M | $3.1M | |
Long-Term Debt | -- | -- | $30.9K | $24.9K | $18.5K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $65K | $1M | $2.5M | $2.2M | $4.1M | |
Common Stock | $3.1M | $10.3M | $29.8M | $58.8M | $113M | |
Other Common Equity Adj | $788.3K | -- | -- | -- | -- | |
Common Equity | $2M | $1.8M | $7.4M | $20.6M | $51.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2M | $1.8M | $7.4M | $20.6M | $51.3M | |
Total Liabilities and Equity | $2M | $2.8M | $9.9M | $22.8M | $55.4M | |
Cash and Short Terms | $1.1M | $1.7M | $5.7M | $11.9M | $33.2M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.1M | $1.7M | $5.7M | $11.9M | $33.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $29.2K | $340 | $22.5K | $228.4K | $2.3M | |
Inventory | -- | -- | -- | -- | $16.9K | |
Prepaid Expenses | $17.1K | $49.1K | $144.2K | $588.4K | $6.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $1.2M | $1.7M | $5.8M | $12.8M | $41.5M | |
Property Plant And Equipment | $862.8K | $1M | $3.8M | $7M | $13.9M | |
Long-Term Investments | -- | -- | $250K | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $2M | $2.8M | $9.9M | $22.8M | $55.4M | |
Accounts Payable | $3.8K | $286.9K | $1.7M | $711K | $1.3M | |
Accrued Expenses | -- | $258K | $221.6K | $455.2K | $259.3K | |
Current Portion Of Long-Term Debt | -- | -- | $5.6K | $6K | $6.4K | |
Current Portion Of Capital Lease Obligations | $17.8K | $81.1K | $128.7K | $376.7K | $439.4K | |
Other Current Liabilities | $18.1K | -- | -- | -- | -- | |
Total Current Liabilities | $65K | $637K | $2.1M | $1.6M | $3.1M | |
Long-Term Debt | -- | -- | $30.9K | $24.9K | $18.5K | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $65K | $1M | $2.5M | $2.2M | $4.1M | |
Common Stock | $3.1M | $10.3M | $29.8M | $58.8M | $113M | |
Other Common Equity Adj | $788.3K | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2M | $1.8M | $7.4M | $20.6M | $51.3M | |
Total Liabilities and Equity | $2M | $2.8M | $9.9M | $22.8M | $55.4M | |
Cash and Short Terms | $1.1M | $1.7M | $5.7M | $11.9M | $33.2M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$13.2M | -$21.5M | -$17.4M | -$21.8M | |
Depreciation & Amoritzation | -- | $9.3K | $153.4K | $426.5K | $645.9K | |
Stock-Based Compensation | -- | $4.1M | $8.3M | $2.6M | $3.8M | |
Change in Accounts Receivable | -- | -$34.4K | -$98.8K | -$650.1K | -$2.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$3.6M | -$12.1M | -$15.9M | -$18.6M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$89.5K | -$571.6K | -$3.1M | -$5.7M | -$6.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $38.7K | -- | -- | |
Long-Term Debt Repaid | -- | -$6.5K | -$81K | -$518.3K | -$423.8K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $2.2M | -$430.8K | -$1.5M | -$1.3M | |
Cash From Financing | -$24.7K | $5.8M | $19.4M | $27.9M | $46.6M | |
Beginning Cash (CF) | $1.7M | -- | $1.7M | $5.7M | $11.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$561.3K | $1.7M | $4.2M | $6.3M | $21.5M | |
Ending Cash (CF) | $1.1M | $1.7M | $5.7M | $11.9M | $33.2M | |
Levered Free Cash Flow | -- | -$4.1M | -$15M | -$18.6M | -$26.7M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$805K | -$3M | -$3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$89K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $14.2M | -$86K | $4M | |
Cash From Financing | -- | -- | $14.3M | $109K | $4M | |
Beginning Cash (CF) | -- | -- | $5.7M | $11.9M | $33.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -$80K | -$173K | -$324K | |
Additions / Reductions | -- | -- | $9.3M | -$6.6M | -$2.4M | |
Ending Cash (CF) | -- | -- | $14.9M | $5.1M | $30.4M | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-01-04 | 2022-01-04 | 2023-01-04 | 2024-01-04 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$805K | -$3M | -$3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$89K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $14.2M | -$86K | $4M | |
Cash From Financing | -- | -- | $14.3M | $109K | $4M | |
Beginning Cash (CF) | -- | -- | $5.7M | $11.9M | $33.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -$80K | -$173K | -$324K | |
Additions / Reductions | -- | -- | $9.3M | -$6.6M | -$2.4M | |
Ending Cash (CF) | -- | -- | $14.9M | $5.1M | $30.4M | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.